{
  "DOI": "10.1007/s10689-013-9607-1",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-013-9607-1",
  "alternative-id": [
    "9607"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Kui",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Xiao-qin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Bin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Lin",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2013,
        2,
        9
      ]
    ],
    "date-time": "2013-02-09T02:37:28Z",
    "timestamp": 1360377448000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        7,
        9
      ]
    ],
    "date-time": "2019-07-09T13:34:40Z",
    "timestamp": 1562679280000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        27
      ]
    ],
    "date-time": "2024-04-27T11:54:35Z",
    "timestamp": 1714218875716
  },
  "is-referenced-by-count": 79,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2013,
        2,
        9
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2013,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2013,
            2,
            9
          ]
        ],
        "date-time": "2013-02-09T00:00:00Z",
        "timestamp": 1360368000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9607-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-013-9607-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-013-9607-1",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "449-458",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2013,
        2,
        9
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2013,
        2,
        9
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1007/s00401-007-0243-4",
      "author": "DN Louis",
      "doi-asserted-by": "crossref",
      "first-page": "97",
      "issue": "2",
      "journal-title": "Acta Neuropathol",
      "key": "9607_CR1",
      "unstructured": "Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. doi: 10.1007/s00401-007-0243-4",
      "volume": "114",
      "year": "2007"
    },
    {
      "DOI": "10.1056/NEJMoa043330",
      "author": "R Stupp",
      "doi-asserted-by": "crossref",
      "first-page": "987",
      "issue": "10",
      "journal-title": "N Engl J Med",
      "key": "9607_CR2",
      "unstructured": "Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi: 10.1056/NEJMoa043330",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1016/S1470-2045(09)70025-7",
      "author": "R Stupp",
      "doi-asserted-by": "crossref",
      "first-page": "459",
      "issue": "5",
      "journal-title": "Lancet Oncol",
      "key": "9607_CR3",
      "unstructured": "Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459–466. doi: 10.1016/S1470-2045(09)70025-7",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1126/science.1164382",
      "author": "DW Parsons",
      "doi-asserted-by": "crossref",
      "first-page": "1807",
      "issue": "5897",
      "journal-title": "Science",
      "key": "9607_CR4",
      "unstructured": "Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812. doi: 10.1126/science.1164382",
      "volume": "321",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJMra0708126",
      "author": "PY Wen",
      "doi-asserted-by": "crossref",
      "first-page": "492",
      "issue": "5",
      "journal-title": "N Engl J Med",
      "key": "9607_CR5",
      "unstructured": "Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507. doi: 10.1056/NEJMra0708126",
      "volume": "359",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S1383-5742(00)00017-X",
      "author": "AE Pegg",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "issue": "2–3",
      "journal-title": "Mutat Res",
      "key": "9607_CR6",
      "unstructured": "Pegg AE (2000) Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 462(2–3):83–100",
      "volume": "462",
      "year": "2000"
    },
    {
      "DOI": "10.1002/bies.950161110",
      "author": "P Karran",
      "doi-asserted-by": "crossref",
      "first-page": "833",
      "issue": "11",
      "journal-title": "BioEssays",
      "key": "9607_CR7",
      "unstructured": "Karran P, Bignami M (1994) DNA damage tolerance, mismatch repair and genome instability. BioEssays 16(11):833–839. doi: 10.1002/bies.950161110",
      "volume": "16",
      "year": "1994"
    },
    {
      "DOI": "10.1016/S1470-2045(07)70384-4",
      "author": "T Gorlia",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "issue": "1",
      "journal-title": "Lancet Oncol",
      "key": "9607_CR8",
      "unstructured": "Gorlia T, van den Bent MJ, Hegi ME et al (2008) Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981–22981/CE.3. Lancet Oncol 9(1):29–38. doi: 10.1016/S1470-2045(07)70384-4",
      "volume": "9",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJM200011093431901",
      "author": "M Esteller",
      "doi-asserted-by": "crossref",
      "first-page": "1350",
      "issue": "19",
      "journal-title": "N Engl J Med",
      "key": "9607_CR9",
      "unstructured": "Esteller M, Garcia-Foncillas J, Andion E et al (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343(19):1350–1354. doi: 10.1056/NEJM200011093431901",
      "volume": "343",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-0230",
      "author": "M Brell",
      "doi-asserted-by": "crossref",
      "first-page": "5167",
      "issue": "14",
      "journal-title": "Clin Cancer Res",
      "key": "9607_CR10",
      "unstructured": "Brell M, Tortosa A, Verger E et al (2005) Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 11(14):5167–5174. doi: 10.1158/1078-0432.CCR-05-0230",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1002/(SICI)1097-0258(19981230)17:24\u003c2815::AID-SIM110\u003e3.0.CO;2-8",
      "author": "MK Parmar",
      "doi-asserted-by": "crossref",
      "first-page": "2815",
      "issue": "24",
      "journal-title": "Stat Med",
      "key": "9607_CR11",
      "unstructured": "Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815–2834",
      "volume": "17",
      "year": "1998"
    },
    {
      "DOI": "10.1002/sim.1186",
      "author": "JP Higgins",
      "doi-asserted-by": "crossref",
      "first-page": "1539",
      "issue": "11",
      "journal-title": "Stat Med",
      "key": "9607_CR12",
      "unstructured": "Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi: 10.1002/sim.1186",
      "volume": "21",
      "year": "2002"
    },
    {
      "author": "N Mantel",
      "first-page": "719",
      "issue": "4",
      "journal-title": "J Natl Cancer Inst",
      "key": "9607_CR13",
      "unstructured": "Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748",
      "volume": "22",
      "year": "1959"
    },
    {
      "DOI": "10.1016/0197-2456(86)90046-2",
      "author": "R DerSimonian",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "issue": "3",
      "journal-title": "Control Clin Trials",
      "key": "9607_CR14",
      "unstructured": "DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188",
      "volume": "7",
      "year": "1986"
    },
    {
      "DOI": "10.2307/2533446",
      "author": "CB Begg",
      "doi-asserted-by": "crossref",
      "first-page": "1088",
      "issue": "4",
      "journal-title": "Biometrics",
      "key": "9607_CR15",
      "unstructured": "Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101",
      "volume": "50",
      "year": "1994"
    },
    {
      "DOI": "10.1007/s12032-011-9901-4",
      "author": "K Tang",
      "doi-asserted-by": "crossref",
      "first-page": "1292",
      "issue": "2",
      "journal-title": "Med Oncol",
      "key": "9607_CR16",
      "unstructured": "Tang K, Jin Q, Yan W et al (2012) Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients. Med Oncol 29(2):1292–1296. doi: 10.1007/s12032-011-9901-4",
      "volume": "29",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cncr.25637",
      "author": "K Motomura",
      "doi-asserted-by": "crossref",
      "first-page": "1721",
      "issue": "8",
      "journal-title": "Cancer",
      "key": "9607_CR17",
      "unstructured": "Motomura K, Natsume A, Kishida Y et al (2011) Benefits of interferon-beta and temozolomide combination therapy for newly diagnosed primary glioblastoma with the unmethylated MGMT promoter: a multicenter study. Cancer 117(8):1721–1730. doi: 10.1002/cncr.25637",
      "volume": "117",
      "year": "2011"
    },
    {
      "DOI": "10.1186/1471-2164-11-701",
      "author": "A Etcheverry",
      "doi-asserted-by": "crossref",
      "first-page": "701",
      "journal-title": "BMC Genomics",
      "key": "9607_CR18",
      "unstructured": "Etcheverry A, Aubry M, de Tayrac M et al (2010) DNA methylation in glioblastoma: impact on gene expression and clinical outcome. BMC Genomics 11:701. doi: 10.1186/1471-2164-11-701",
      "volume": "11",
      "year": "2010"
    },
    {
      "author": "YS Kim",
      "journal-title": "Int J Radiat Oncol Biol Phys",
      "key": "9607_CR19",
      "unstructured": "Kim YS, Kim SH, Cho J et al (2012) MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a Single-Institution Study. Int J Radiat Oncol Biol Phys. doi: 10.1016/j.ijrobp.2011.12.086",
      "year": "2012"
    },
    {
      "DOI": "10.1002/cncr.27441",
      "doi-asserted-by": "crossref",
      "key": "9607_CR20",
      "unstructured": "Lechapt-Zalcman E, Levallet G, Dugue AE, et al (2012) O(6)-Methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide. Cancer. doi: 10.1002/cncr.27441"
    },
    {
      "DOI": "10.1002/ijc.27385",
      "doi-asserted-by": "crossref",
      "key": "9607_CR21",
      "unstructured": "Reifenberger G, Hentschel B, Felsberg J, et al (2011) Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. Int J Cancer. doi: 10.1002/ijc.27385"
    },
    {
      "DOI": "10.1002/ijc.26083",
      "author": "J Felsberg",
      "doi-asserted-by": "crossref",
      "first-page": "659",
      "issue": "3",
      "journal-title": "Int J Cancer",
      "key": "9607_CR22",
      "unstructured": "Felsberg J, Thon N, Eigenbrod S et al (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer 129(3):659–670. doi: 10.1002/ijc.26083",
      "volume": "129",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s12094-011-0714-x",
      "author": "C Balana",
      "doi-asserted-by": "crossref",
      "first-page": "677",
      "issue": "9",
      "journal-title": "Clin Transl Oncol",
      "key": "9607_CR23",
      "unstructured": "Balana C, Carrato C, Ramirez JL et al (2011) Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients. Clin Transl Oncol 13(9):677–685",
      "volume": "13",
      "year": "2011"
    },
    {
      "DOI": "10.1111/j.1349-7006.2011.02092.x",
      "author": "R Lakomy",
      "doi-asserted-by": "crossref",
      "first-page": "2186",
      "issue": "12",
      "journal-title": "Cancer Sci",
      "key": "9607_CR24",
      "unstructured": "Lakomy R, Sana J, Hankeova S et al (2011) MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci 102(12):2186–2190. doi: 10.1111/j.1349-7006.2011.02092.x",
      "volume": "102",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10147-010-0065-6",
      "author": "Y Sonoda",
      "doi-asserted-by": "crossref",
      "first-page": "352",
      "issue": "4",
      "journal-title": "Int J Clin Oncol",
      "key": "9607_CR25",
      "unstructured": "Sonoda Y, Yokosawa M, Saito R et al (2010) O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma. Int J Clin Oncol 15(4):352–358. doi: 10.1007/s10147-010-0065-6",
      "volume": "15",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11060-010-0324-4",
      "author": "G Minniti",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "issue": "2",
      "journal-title": "J Neurooncol",
      "key": "9607_CR26",
      "unstructured": "Minniti G, Salvati M, Arcella A et al (2011) Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol 102(2):311–316. doi: 10.1007/s11060-010-0324-4",
      "volume": "102",
      "year": "2011"
    },
    {
      "DOI": "10.1136/jnnp.2010.214593",
      "author": "N Thon",
      "doi-asserted-by": "crossref",
      "first-page": "441",
      "issue": "4",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "9607_CR27",
      "unstructured": "Thon N, Eigenbrod S, Grasbon-Frodl EM et al (2011) Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide. J Neurol Neurosurg Psychiatry 82(4):441–446. doi: 10.1136/jnnp.2010.214593",
      "volume": "82",
      "year": "2011"
    },
    {
      "DOI": "10.1200/JCO.2009.23.0805",
      "author": "M Weller",
      "doi-asserted-by": "crossref",
      "first-page": "5743",
      "issue": "34",
      "journal-title": "J Clin Oncol",
      "key": "9607_CR28",
      "unstructured": "Weller M, Felsberg J, Hartmann C et al (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27(34):5743–5750. doi: 10.1200/JCO.2009.23.0805",
      "volume": "27",
      "year": "2009"
    },
    {
      "author": "S Wemmert",
      "first-page": "1743",
      "issue": "6",
      "journal-title": "Int J Oncol",
      "key": "9607_CR29",
      "unstructured": "Wemmert S, Bettscheider M, Alt S et al (2009) p15 promoter methylation—a novel prognostic marker in glioblastoma patients. Int J Oncol 34(6):1743–1748",
      "volume": "34",
      "year": "2009"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-03-0384",
      "author": "ME Hegi",
      "doi-asserted-by": "crossref",
      "first-page": "1871",
      "issue": "6",
      "journal-title": "Clin Cancer Res",
      "key": "9607_CR30",
      "unstructured": "Hegi ME, Diserens AC, Godard S et al (2004) Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10(6):1871–1874",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1159/000170088",
      "author": "I Zawlik",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "issue": "1",
      "journal-title": "Neuroepidemiology",
      "key": "9607_CR31",
      "unstructured": "Zawlik I, Vaccarella S, Kita D, Mittelbronn M, Franceschi S, Ohgaki H (2009) Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology 32(1):21–29. doi: 10.1159/000170088",
      "volume": "32",
      "year": "2009"
    },
    {
      "DOI": "10.1111/j.1440-1789.2008.00998.x",
      "author": "CK Park",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "issue": "4",
      "journal-title": "Neuropathology",
      "key": "9607_CR32",
      "unstructured": "Park CK, Park SH, Lee SH et al (2009) Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin. Neuropathology 29(4):443–449. doi: 10.1111/j.1440-1789.2008.00998.x",
      "volume": "29",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s00701-009-0387-1",
      "author": "Y Sonoda",
      "doi-asserted-by": "crossref",
      "first-page": "1349",
      "issue": "11",
      "journal-title": "Acta Neurochir",
      "key": "9607_CR33",
      "unstructured": "Sonoda Y, Kumabe T, Watanabe M et al (2009) Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir 151(11):1349–1358. doi: 10.1007/s00701-009-0387-1",
      "volume": "151",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cncr.24546",
      "author": "P Metellus",
      "doi-asserted-by": "crossref",
      "first-page": "4783",
      "issue": "20",
      "journal-title": "Cancer",
      "key": "9607_CR34",
      "unstructured": "Metellus P, Coulibaly B, Nanni I et al (2009) Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. Cancer 115(20):4783–4794. doi: 10.1002/cncr.24546",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.1227/01.NEU.0000357325.90347.A1",
      "doi-asserted-by": "crossref",
      "key": "9607_CR35",
      "unstructured": "Cao VT, Jung TY, Jung S et al (2009) The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery 65(5):866–75; discussion 75. doi: 10.1227/01.NEU.0000357325.90347.A1"
    },
    {
      "DOI": "10.1371/journal.pone.0033449",
      "author": "A Christians",
      "doi-asserted-by": "crossref",
      "first-page": "e33449",
      "issue": "3",
      "journal-title": "PLoS One",
      "key": "9607_CR36",
      "unstructured": "Christians A, Hartmann C, Benner A et al (2012) Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PLoS One 7(3):e33449. doi: 10.1371/journal.pone.0033449",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1186/1748-717X-6-115",
      "author": "SE Combs",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "Radiat Oncol",
      "key": "9607_CR37",
      "unstructured": "Combs SE, Rieken S, Wick W et al (2011) Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward and one step back? Radiat Oncol 6:115. doi: 10.1186/1748-717X-6-115",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s11060-011-0668-4",
      "author": "SH Yang",
      "doi-asserted-by": "crossref",
      "first-page": "243",
      "issue": "2",
      "journal-title": "J Neurooncol",
      "key": "9607_CR38",
      "unstructured": "Yang SH, Lee KS, Yang HJ et al (2012) O(6)-Methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomas. J Neurooncol 106(2):243–250. doi: 10.1007/s11060-011-0668-4",
      "volume": "106",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.neuroimage.2011.09.076",
      "author": "BM Ellingson",
      "doi-asserted-by": "crossref",
      "first-page": "908",
      "issue": "2",
      "journal-title": "NeuroImage",
      "key": "9607_CR39",
      "unstructured": "Ellingson BM, Cloughesy TF, Pope WB et al (2012) Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. NeuroImage 59(2):908–916. doi: 10.1016/j.neuroimage.2011.09.076",
      "volume": "59",
      "year": "2012"
    },
    {
      "DOI": "10.1093/neuonc/noq162",
      "author": "CK Park",
      "doi-asserted-by": "crossref",
      "first-page": "195",
      "issue": "2",
      "journal-title": "Neuro-oncology",
      "key": "9607_CR40",
      "unstructured": "Park CK, Kim J, Yim SY et al (2011) Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients. Neuro-oncology 13(2):195–202. doi: 10.1093/neuonc/noq162",
      "volume": "13",
      "year": "2011"
    },
    {
      "author": "BM Costa",
      "first-page": "1655",
      "issue": "6",
      "journal-title": "Oncol Rep",
      "key": "9607_CR41",
      "unstructured": "Costa BM, Caeiro C, Guimaraes I et al (2010) Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study. Oncol Rep 23(6):1655–1662",
      "volume": "23",
      "year": "2010"
    },
    {
      "DOI": "10.1093/neuonc/nop050",
      "author": "AA Brandes",
      "doi-asserted-by": "crossref",
      "first-page": "283",
      "issue": "3",
      "journal-title": "Neuro-oncology",
      "key": "9607_CR42",
      "unstructured": "Brandes AA, Franceschi E, Tosoni A et al (2010) O(6)-Methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neuro-oncology 12(3):283–288. doi: 10.1093/neuonc/nop050",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1186/1471-2407-10-48",
      "author": "L Morandi",
      "doi-asserted-by": "crossref",
      "first-page": "48",
      "journal-title": "BMC Cancer",
      "key": "9607_CR43",
      "unstructured": "Morandi L, Franceschi E, de Biase D et al (2010) Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference. BMC Cancer 10:48. doi: 10.1186/1471-2407-10-48",
      "volume": "10",
      "year": "2010"
    },
    {
      "DOI": "10.1093/neuonc/nop020",
      "author": "AL Rivera",
      "doi-asserted-by": "crossref",
      "first-page": "116",
      "issue": "2",
      "journal-title": "Neuro-oncology",
      "key": "9607_CR44",
      "unstructured": "Rivera AL, Pelloski CE, Gilbert MR et al (2010) MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro-oncology 12(2):116–121. doi: 10.1093/neuonc/nop020",
      "volume": "12",
      "year": "2010"
    },
    {
      "DOI": "10.1097/PAT.0b013e328340bb26",
      "author": "E Zunarelli",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "issue": "1",
      "journal-title": "Pathology",
      "key": "9607_CR45",
      "unstructured": "Zunarelli E, Bigiani N, Sartori G, Migaldi M, Sgambato A, Maiorana A (2011) INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival. Pathology 43(1):17–23. doi: 10.1097/PAT.0b013e328340bb26",
      "volume": "43",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s11060-009-0031-1",
      "author": "L Karayan-Tapon",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "issue": "3",
      "journal-title": "J Neurooncol",
      "key": "9607_CR46",
      "unstructured": "Karayan-Tapon L, Quillien V, Guilhot J et al (2010) Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods. J Neurooncol 97(3):311–322. doi: 10.1007/s11060-009-0031-1",
      "volume": "97",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cncr.24406",
      "author": "AA Brandes",
      "doi-asserted-by": "crossref",
      "first-page": "3512",
      "issue": "15",
      "journal-title": "Cancer",
      "key": "9607_CR47",
      "unstructured": "Brandes AA, Franceschi E, Tosoni A et al (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115(15):3512–3518. doi: 10.1002/cncr.24406",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.3171/JNS/2008/109/12/S17",
      "author": "KA Smith",
      "doi-asserted-by": "crossref",
      "first-page": "106",
      "issue": "Suppl",
      "journal-title": "J Neurosurg",
      "key": "9607_CR48",
      "unstructured": "Smith KA, Ashby LS, Gonzalez LF et al (2008) Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme. J Neurosurg 109(Suppl):106–117. doi: 10.3171/JNS/2008/109/12/S17",
      "volume": "109",
      "year": "2008"
    },
    {
      "author": "M Esteller",
      "first-page": "793",
      "issue": "4",
      "journal-title": "Cancer Res",
      "key": "9607_CR49",
      "unstructured": "Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59(4):793–797",
      "volume": "59",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.humpath.2009.01.005",
      "author": "JI Kim",
      "doi-asserted-by": "crossref",
      "first-page": "934",
      "issue": "7",
      "journal-title": "Hum Pathol",
      "key": "9607_CR50",
      "unstructured": "Kim JI, Suh JT, Choi KU et al (2009) Inactivation of O6-methylguanine-DNA methyltransferase in soft tissue sarcomas: association with K-ras mutations. Hum Pathol 40(7):934–941. doi: 10.1016/j.humpath.2009.01.005",
      "volume": "40",
      "year": "2009"
    },
    {
      "author": "M Citron",
      "first-page": "4131",
      "issue": "16",
      "journal-title": "Cancer Res",
      "key": "9607_CR51",
      "unstructured": "Citron M, Decker R, Chen S et al (1991) O6-Methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary. Cancer Res 51(16):4131–4134",
      "volume": "51",
      "year": "1991"
    },
    {
      "author": "JR Silber",
      "first-page": "3416",
      "issue": "14",
      "journal-title": "Cancer Res",
      "key": "9607_CR52",
      "unstructured": "Silber JR, Mueller BA, Ewers TG, Berger MS (1993) Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res 53(14):3416–3420",
      "volume": "53",
      "year": "1993"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0596",
      "author": "A Chakravarti",
      "doi-asserted-by": "crossref",
      "first-page": "4738",
      "issue": "15",
      "journal-title": "Clin Cancer Res",
      "key": "9607_CR53",
      "unstructured": "Chakravarti A, Erkkinen MG, Nestler U et al (2006) Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms. Clin Cancer Res 12(15):4738–4746. doi: 10.1158/1078-0432.CCR-06-0596",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.2176/nmc.50.713",
      "author": "R Nishikawa",
      "doi-asserted-by": "crossref",
      "first-page": "713",
      "issue": "9",
      "journal-title": "Neurol Med Chir",
      "key": "9607_CR54",
      "unstructured": "Nishikawa R (2010) Standard therapy for glioblastoma—a review of where we are. Neurol Med Chir 50(9):713–719",
      "volume": "50",
      "year": "2010"
    },
    {
      "DOI": "10.1056/NEJMoa043331",
      "author": "ME Hegi",
      "doi-asserted-by": "crossref",
      "first-page": "997",
      "issue": "10",
      "journal-title": "N Engl J Med",
      "key": "9607_CR55",
      "unstructured": "Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997–1003. doi: 10.1056/NEJMoa043331",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1097/CCO.0b013e3282f075f3",
      "author": "A Idbaih",
      "doi-asserted-by": "crossref",
      "first-page": "606",
      "issue": "6",
      "journal-title": "Curr Opin Oncol",
      "key": "9607_CR56",
      "unstructured": "Idbaih A, Omuro A, Ducray F, Hoang-Xuan K (2007) Molecular genetic markers as predictors of response to chemotherapy in gliomas. Curr Opin Oncol 19(6):606–611. doi: 10.1097/CCO.0b013e3282f075f3",
      "volume": "19",
      "year": "2007"
    }
  ],
  "reference-count": 56,
  "references-count": 56,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-013-9607-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis"
  ],
  "type": "journal-article",
  "volume": "12"
}